Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Bragado, Paloma ^a   Estrada, Yeriel ^a   Sosa, Maria Soledad ^a   Avivar Valderas, Alvaro ^a   Cannan, David ^a   Genden, Eric ^a   Teng, Marita ^a   Ranganathan, Aparna C ^a   Wen, Huei Chi ^a   Kapoor, Avnish ^a   Bernstein, Emily ^a   Aguirre Ghiso, Julio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA6 INTEGRIN; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR EZH2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURFACE; CHICKEN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR INITIATING CELL; TUMOR XENOGRAFT; ANIMAL; CANCER STEM CELL; CHICK EMBRYO; HEAD AND NECK TUMOR; METABOLISM; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

MUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHICK EMBRYO; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED NOD; MICE, NUDE; NEOPLASTIC STEM CELLS;

EID: 84856044714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029974     Document Type: Article

References (62)

1. Myers EN, (2010) Head and neck oncology-2010, part II. Otolaryngol Pol 64: 204-214.
2. Myers EN, (2010) Head and neck oncology-2010, Part I. Otolaryngol Pol 64: 136-146.
3. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978.
4. Lukacs RU, Memarzadeh S, Wu H, Witte ON, (2010) Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7: 682-693.
5. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, et al. (2010) Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32: 1195-1201.
6. Brummendorf TH, Dragowska W, Lansdorp PM, (1999) Asymmetric cell divisions in hematopoietic stem cells. Ann N Y Acad Sci 872: 265-272; discussion 272-263.
7. Brummendorf TH, Dragowska W, Zijlmans J, Thornbury G, Lansdorp PM, (1998) Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 188: 1117-1124.
8. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, et al. (2010) Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized. Cancer Cell 18: 510-523.
9. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
10. Adams JM, Strasser A, (2008) Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res 68: 4018-4021.
11. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A, (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317: 337.
12. Lobo NA, Shimono Y, Qian D, Clarke MF, (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
13. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
14. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
15. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, et al. (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71: 3098-3109.
16. Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, et al. (2008) A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res 68: 6932-6941.
17. Weinberg R, Fisher DE, Rich J, (2010) Dynamic and transient cancer stem cells nurture melanoma. Nat Med 16: 758.
18. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, et al. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146: 633-644.
19. Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK, (2004) Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth. Cancer Research 64: 7336-7345.
20. Ossowski L, Reich E, (1983) Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell 33: 323-333.
21. Dontu G, Liu S, Wicha MS, (2005) Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 1: 207-213.
22. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis. Cancer Research 69: 3382-3389.
23. Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, et al. (1999) Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 96: 9118-9123.
24. Ossowski L, Reich E, (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35: 611-619.
25. Ossowski L, (1988) Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52: 321-328.
26. Ossowski L, Russo H, Gartner M, Wilson EL, (1987) Growth of a human carcinoma (HEp3) in nude mice: rapid and efficient metastasis. J Cell Physiol 133: 288-296.
27. Izadyar F, Wong J, Maki C, Pacchiarotti J, Ramos T, et al. (2011) Identification and characterization of repopulating spermatogonial stem cells from the adult human testis. Hum Reprod 26: 1296-1306.
28. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, et al. (2004) Defining the epithelial stem cell niche in skin. Science 303: 359-363.
29. Garzino-Demo P, Carrozzo M, Trusolino L, Savoia P, Gandolfo S, et al. (1998) Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol 34: 204-210.
30. Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, et al. (2011) Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218-221.
31. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, et al. (2009) High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. Journal of Cellular and Molecular Medicine 13: 2236-2252.
32. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, et al. (2010) Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & Neck 32: 1195-1201.
33. Inoue K, Aoi N, Sato T, Yamauchi Y, Suga H, et al. (2009) Differential expression of stem-cell-associated markers in human hair follicle epithelial cells. Lab Invest 89: 844-856.
34. Jiang S, Zhao L, Purandare B, Hantash B, (2010) Differential expression of stem cell markers in human follicular bulge and interfollicular epidermal compartments. Histochemistry and Cell Biology 133: 455-465.
35. Cho DY, Lin SZ, Yang WK, Hsu DM, Lin HL, et al. (2011) The Role of Cancer Stem Cells (CD133+) in Malignant Gliomas. Cell Transplant 20: 121-125.
36. Essers MA, Trumpp A, (2010) Targeting leukemic stem cells by breaking their dormancy. Mol Oncol 4: 443-450.
37. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L, (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63: 1684-1695.
38. Graziano M, St-Pierre Y, Beauchemin C, Desrosiers M, Potworowski EF, (1998) The fate of thymocytes labeled in vivo with CFSE. Exp Cell Res 240: 75-85.
39. Wenzel CT, Scher RL, Richtsmeier WJ, (1995) Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links. Arch Otolaryngol Head Neck Surg 121: 1279-1286.
40. Cortesina G, Sacchi M, Bussi M, Panizzut B, Ferro S, et al. (1995) Integrin expression in head and neck cancers. Acta Otolaryngol 115: 328-330.
41. Aguirre Ghiso JA, Kovalski K, Ossowski L, (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104.
42. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L, (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1: 445-457.
43. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L, (2001) Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12: 863-879.
44. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, et al. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
45. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et al. (2010) A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth. Cell 141: 583-594.
46. Lindeman LC, Winata CL, Aanes H, Mathavan S, Alestrom P, et al. (2010) Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos. Int J Dev Biol 54: 803-813.
47. Margueron R, Li G, Sarma K, Blais A, Zavadil J, et al. (2008) Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms. Molecular Cell 32: 503-518.
48. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, et al. (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22: 5323-5335.
49. Simons BD, Clevers H, (2011) Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145: 851-862.
50. MacArthur BD, Please CP, Oreffo ROC, (2008) Stochasticity and the Molecular Mechanisms of Induced Pluripotency. PLoS ONE 3: e3086.
51. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, et al. (2008) The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell 133: 704-715.
52. Rosen JM, Jordan CT, (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
53. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, et al. (1997) The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. Embo J 16: 2365-2375.
54. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, et al. (2002) beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2: 205-216.
55. Trusolino L, Cavassa S, Angelini P, Ando M, Bertotti A, et al. (2000) HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. Faseb J 14: 1629-1640.
56. Jo M, Eastman BM, Webb DL, Stoletov K, Klemke R, et al. (2010) Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell-like Properties in Breast Cancer Cells. Cancer Research 70: 8948-8958.
57. Yang L, Avila H, Wang H, Trevino J, Gallick GE, et al. (2006) Plasticity in Urokinase-Type Plasminogen Activator Receptor (uPAR) Display in Colon Cancer Yields Metastable Subpopulations Oscillating in Cell Surface uPAR Density-Implications in Tumor Progression. Cancer Research 66: 7957-7967.
58. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
59. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, et al. (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7: 249-257.
60. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA, (2007) A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88.
61. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, et al. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
62. Aguirre Ghiso JA, Alonso DF, Farias EF, Gomez DE, de Kier Joffe EB, (1999) Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 263: 295-304.